ARTICLE | Company News
Management tracks
March 5, 2015 1:52 AM UTC
Antibody developer Xoma Corp. (NASDAQ:XOMA) promoted Thomas Burns to CFO from VP of finance. Burnes succeeds Fred Kurland, who plans to retire on April 3.
Cancer company Adaptimmune Ltd. (Abingdon, U.K.) hired Rafael Amado as CMO and Adrian Rawcliffe as CFO, both effective March 16. Amado was SVP and head of oncology R&D at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Rawcliffe was SVP of finance of GSK's North American pharmaceuticals business. ...